Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Identification and validation of genes involved in cervical tumourigenesis.

Rajkumar T, Sabitha K, Vijayalakshmi N, Shirley S, Bose MV, Gopal G, Selvaluxmy G.

BMC Cancer. 2011 Feb 22;11:80. doi: 10.1186/1471-2407-11-80.

2.

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.

Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ.

J Natl Cancer Inst. 2004 Feb 18;96(4):294-305.

PMID:
14970278
3.

Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.

Noel JC, Fernandez-Aguilar S, Fayt I, Buxant F, Ansion MH, Simon P, Anaf V.

Acta Obstet Gynecol Scand. 2005 Nov;84(11):1119-23.

PMID:
16232183
4.

Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.

Howitt BE, Nucci MR, Drapkin R, Crum CP, Hirsch MS.

Am J Surg Pathol. 2013 Jan;37(1):89-97. doi: 10.1097/PAS.0b013e3182753f5a.

PMID:
23211296
5.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
6.

p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia.

Bulten J, van der Avoort IA, Melchers WJ, Massuger LF, Grefte JM, Hanselaar AG, de Wilde PC.

Gynecol Oncol. 2006 Jun;101(3):487-94. Epub 2006 Jan 9.

PMID:
16406113
7.

Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix.

Murphy N, Ring M, Heffron CC, Martin CM, McGuinness E, Sheils O, O'Leary JJ.

Mod Pathol. 2005 Jun;18(6):844-9.

8.

Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues.

Shen Y, Li Y, Ye F, Wang F, Wan X, Lu W, Xie X.

Exp Mol Med. 2011 Jun 30;43(6):358-66.

9.
10.

p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ.

J Clin Pathol. 2003 Jan;56(1):56-63.

11.

Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.

Lee WY, Huang SC, Hsu KF, Tzeng CC, Shen WL.

Gynecol Oncol. 2008 Feb;108(2):377-84. Epub 2007 Dec 4.

PMID:
18055005
12.

Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.

Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, Powers HJ.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2782-9. doi: 10.1158/1055-9965.EPI-09-0493. Epub 2009 Sep 15.

13.

Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia.

Kendrick JE, Conner MG, Huh WK.

J Low Genit Tract Dis. 2007 Jan;11(1):25-8.

PMID:
17194947
14.
15.

[Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].

Liao YD, Xu H, Han Q, Lei J, Zhang YY, Wang ZH.

Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):360-4. Chinese.

PMID:
17892132
16.

Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis.

Gu J, Li X, Liang Y, Qiao L, Ran D, Lu Y, Li X, Wei W, Zheng Q.

Int J Clin Exp Pathol. 2013;6(4):669-77. Epub 2013 Mar 15.

17.

Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma.

Oh EK, Kim YW, Kim IW, Liu HB, Lee KH, Chun HJ, Park DC, Oh EJ, Lee AW, Bae SM, Ahn WS.

Int J Oncol. 2012 Dec;41(6):2038-46. doi: 10.3892/ijo.2012.1644. Epub 2012 Sep 27.

PMID:
23023522
18.

Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues.

Ono A, Kumai T, Koizumi H, Nishikawa H, Kobayashi S, Tadokoro M.

Hum Pathol. 2009 Jan;40(1):41-9. doi: 10.1016/j.humpath.2008.06.010. Epub 2008 Aug 27.

PMID:
18755499
19.

Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

Santin AD, Zhan F, Bignotti E, Siegel ER, Cané S, Bellone S, Palmieri M, Anfossi S, Thomas M, Burnett A, Kay HH, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S.

Virology. 2005 Jan 20;331(2):269-91.

20.

Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.

Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.

Acta Cytol. 2012;56(5):506-14. doi: 10.1159/000338979. Epub 2012 Sep 27.

PMID:
23075891

Supplemental Content

Support Center